Abstract:RationaleIn pulmonary arterial hypertension (PAH), endothelial cells (ECs) exhibit increased migration/proliferation leading to formation of vaso‐occlusive lesions. The mechanisms underlying this pro‐migratory/proliferative state remain unclear. Increased ROS and intracellular Ca2+ concentration ([Ca2+]i) are known to promote migration and proliferation in other vascular beds, and there is evidence for increased oxidant stress and basal [Ca2+]i in ECs from humans with PAH. Although the exact source of increased EC oxidant stress in PAH ECs is not fully known, mitochondria are a significant source of ROS in ECs, and mitochondrial dysfunction is present in human PAH ECs. However, the links between ROS production, elevated [Ca2+]i and enhanced migration and proliferation in PAH ECs are incompletely understood.We previously showed that exogenous ROS increased [Ca2+]i in lung microvascular endothelial cells (MVECs) via the transient receptor potential vanilloid‐4 (TRPV4) calcium channel. To study endogenous ROS production and the possible role of ROS‐induced Ca2+ influx in promoting MVEC migration and proliferation in PAH, we isolated MVECs from the lungs of rats subjected to normoxia (N‐MVEC) or SU5416/hypoxia (SuHx‐MVEC), a robust model of PAH, and examined ROS production, [Ca2+]i, mitochondrial morphology/function and cellular migration and proliferation.MethodsCa2+ was measured using Fura‐2AM‐loaded MLMVEC in a flow chamber perfused with Krebs buffer. Mitochondrial morphology measurements were made using validated algorithms on confocal images of mitochondria in N‐ and SuHx‐MVEC transfected with MitoRFP. ROS measurements were made using the ratiometric ROS sensor roGFP. Migration and proliferation were measured using transwell assay and BrDU incorporation, respectively.ResultsROS levels were increased in SuHx‐MVEC and attenuated following treatment with MitoQ (MQ) a mitochondrion‐specific antioxidant. In SuHx‐MVECs, mitochondrial number, network fragmentation and activation of the fission‐inducing protein dynamin‐related protein 1 were increased, while oxidative phosphorylation and mitochondrial membrane potential were both decreased. Basal [Ca2+]i, migration and proliferation were all increased in SuHx‐MVEC, but similarly attenuated following treatment with: 1) MQ; 2) a global ROS scavenger (TEMPOL); or 3) HC‐067047, a specific TRPV4 inhibitor. While total TRPV4 expression was unchanged between N‐ and SuHx‐MVEC, activation of membrane bound TRPV4 (using the specific agonist GSK1016790A ‐ GSK) produced greater [Ca2+]i influx in SuHx‐MVEC. Biotinylation of TRPV4 revealed greater membrane‐bound expression of TRPV4 in SuHx‐MVEC. Interestingly, quenching mitochondrial ROS attenuated GSK‐induced [Ca2+]i influx in SuHx‐MVEC.ConclusionThese data suggest that, in SuHx‐MVEC, mitochondrial ROS promote membrane translocation of TRPV4, leading to increased basal [Ca2+]i and enhanced migration and proliferation.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Cytochrome P450 Epoxygenase-Dependent Activation of TRPV4 Channel Participates in Enhanced Serotonin-Induced Pulmonary Vasoconstriction in Chronic Hypoxic Pulmonary Hypertension.

Trpv4 Channel Contributes To Serotonin-Induced Pulmonary Vasoconstriction And The Enhanced Vascular Reactivity In Chronic Hypoxic Pulmonary Hypertension

Contributions of Trpv4 to Altered Pulmonary Vasoreactivity in Mice with Pulmonary Hypertension

Classical Transient Receptor Potential 1 and 6 Contribute to Hypoxic Pulmonary Hypertension Through Differential Regulation of Pulmonary Vascular Functions

Trpc1 And Trpc6 Regulate Chronic Hypoxia-Induced Vascular Tone, Vasoreactivity And Pulmonary Hypertension

Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

TRPC4 Aggravates Hypoxic Pulmonary Hypertension by Promoting Pulmonary Endothelial Cell Apoptosis

TRPV1 activation exacerbates hypoxia/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction.

TRPV1 Activation Exacerbates Hypoxia/Reoxygenation-Induced Apoptosis in H9C2 Cells via Calcium Overload and Mitochondrial Dysfunction

Role of Mitochondrial Reactive Oxygen Species (ROS) and TRPV4 Activation in Microvascular Endothelial Cell Dysfunction in PAH.

Transient Receptor Potential Melastatin-8 Activation Induces Relaxation of Pulmonary Artery by Inhibition of Store-Operated Calcium Entry in Normoxic and Chronic Hypoxic Pulmonary Hypertensive Rats

Metabolic Regulation of Mitochondrial Reactive Oxygen Species (mtros) Production and Transient Receptor Potential Vanilloid‐4 (TRPV4) Activation in Microvascular Endothelial Cells in PAH

Fatty Acid Metabolism Promotes TRPV4 Activity in Lung Microvascular Endothelial Cells in Pulmonary Arterial Hypertension.

Mitochondrial ROS (mtros) Production and TRPV4 Translocation/activation in Lung Microvascular Endothelial Cells

A Role for Receptor-Operated Ca2+ Entry in Human Pulmonary Artery Smooth Muscle Cells in Response to Hypoxia.

Preservation of TSPO by chronic intermittent hypobaric hypoxia confers antiarrhythmic activity.

EP3 Receptor Deficiency Attenuates Pulmonary Hypertension Through Suppression of Rho/TGF-β1 Signaling

Mitochondrial ROS Production in Lung Microvascular Endothelial Cells Sensitizes the Transient Receptor Potential Vanilloid‐4 (TRPV4) Channel to Physical and Chemical Stimuli.

Peroxisome Proliferator-Activated Receptor-Γ Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2B Receptor.

Transient Receptor Potential Cation Channel Subfamily V Member 4 Mediates Pyroptosis in Chronic Obstructive Pulmonary Disease.

Chronic Hypoxia Decreases Endothelial Connexin 40, Attenuates Endothelium‐Dependent Hyperpolarization–Mediated Relaxation in Small Distal Pulmonary Arteries, and Leads to Pulmonary Hypertension